vs
Side-by-side financial comparison of ARMSTRONG WORLD INDUSTRIES INC (AWI) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
ARMSTRONG WORLD INDUSTRIES INC is the larger business by last-quarter revenue ($388.3M vs $346.4M, roughly 1.1× HAEMONETICS CORP). HAEMONETICS CORP runs the higher net margin — 28.1% vs 16.9%, a 11.2% gap on every dollar of revenue. On growth, ARMSTRONG WORLD INDUSTRIES INC posted the faster year-over-year revenue change (5.6% vs 4.8%). HAEMONETICS CORP produced more free cash flow last quarter ($209.9M vs $62.2M). Over the past eight quarters, ARMSTRONG WORLD INDUSTRIES INC's revenue compounded faster (9.1% CAGR vs 1.5%).
Armstrong World Industries, Inc. is an international designer and manufacturer of wall and ceiling building materials based in Lancaster, Pennsylvania. As of 2014, AWI had 3,100 employees and a global manufacturing network of 17 facilities, down from 26, including nine plants dedicated to its WAVE joint venture, in 2012.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
AWI vs HAE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2026
| Metric | | |
|---|---|---|
| Revenue | $388.3M | $346.4M |
| Net Profit | $65.5M | $97.3M |
| Gross Margin | 39.8% | 57.2% |
| Operating Margin | 23.7% | 36.1% |
| Net Margin | 16.9% | 28.1% |
| Revenue YoY | 5.6% | 4.8% |
| Net Profit YoY | 5.3% | — |
| EPS (diluted) | $1.51 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $346.4M | ||
| Q4 25 | $388.3M | $339.0M | ||
| Q3 25 | $425.2M | $327.3M | ||
| Q2 25 | $424.6M | $321.4M | ||
| Q1 25 | $382.7M | $330.6M | ||
| Q4 24 | $367.7M | $348.5M | ||
| Q3 24 | $386.6M | $345.5M | ||
| Q2 24 | $365.1M | $336.2M |
| Q1 26 | — | $97.3M | ||
| Q4 25 | $65.5M | $44.7M | ||
| Q3 25 | $86.3M | $38.7M | ||
| Q2 25 | $87.8M | $34.0M | ||
| Q1 25 | $69.1M | $58.0M | ||
| Q4 24 | $62.2M | $37.5M | ||
| Q3 24 | $76.9M | $33.8M | ||
| Q2 24 | $65.9M | $38.4M |
| Q1 26 | — | 57.2% | ||
| Q4 25 | 39.8% | 59.7% | ||
| Q3 25 | 42.0% | 59.5% | ||
| Q2 25 | 41.4% | 59.8% | ||
| Q1 25 | 39.2% | 58.4% | ||
| Q4 24 | 39.1% | 55.5% | ||
| Q3 24 | 42.4% | 54.2% | ||
| Q2 24 | 40.9% | 52.0% |
| Q1 26 | — | 36.1% | ||
| Q4 25 | 23.7% | 19.9% | ||
| Q3 25 | 27.6% | 17.9% | ||
| Q2 25 | 29.0% | 16.8% | ||
| Q1 25 | 25.7% | 21.6% | ||
| Q4 24 | 22.3% | 16.9% | ||
| Q3 24 | 28.8% | 15.0% | ||
| Q2 24 | 26.0% | 11.8% |
| Q1 26 | — | 28.1% | ||
| Q4 25 | 16.9% | 13.2% | ||
| Q3 25 | 20.3% | 11.8% | ||
| Q2 25 | 20.7% | 10.6% | ||
| Q1 25 | 18.1% | 17.5% | ||
| Q4 24 | 16.9% | 10.8% | ||
| Q3 24 | 19.9% | 9.8% | ||
| Q2 24 | 18.0% | 11.4% |
| Q1 26 | — | — | ||
| Q4 25 | $1.51 | $0.95 | ||
| Q3 25 | $1.98 | $0.81 | ||
| Q2 25 | $2.01 | $0.70 | ||
| Q1 25 | $1.58 | $1.17 | ||
| Q4 24 | $1.41 | $0.74 | ||
| Q3 24 | $1.75 | $0.66 | ||
| Q2 24 | $1.50 | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $112.7M | $245.4M |
| Total DebtLower is stronger | — | $1.2B |
| Stockholders' EquityBook value | $900.7M | $796.3M |
| Total Assets | $1.9B | $2.4B |
| Debt / EquityLower = less leverage | — | 1.53× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.4M | ||
| Q4 25 | $112.7M | $363.4M | ||
| Q3 25 | $90.1M | $296.4M | ||
| Q2 25 | $81.1M | $292.9M | ||
| Q1 25 | $82.8M | $306.8M | ||
| Q4 24 | $79.3M | $320.8M | ||
| Q3 24 | $73.7M | $299.3M | ||
| Q2 24 | $73.6M | $344.4M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $796.3M | ||
| Q4 25 | $900.7M | $911.5M | ||
| Q3 25 | $889.2M | $849.2M | ||
| Q2 25 | $837.8M | $882.3M | ||
| Q1 25 | $793.4M | $820.8M | ||
| Q4 24 | $757.1M | $906.9M | ||
| Q3 24 | $717.0M | $878.9M | ||
| Q2 24 | $669.0M | $905.4M |
| Q1 26 | — | $2.4B | ||
| Q4 25 | $1.9B | $2.5B | ||
| Q3 25 | $1.9B | $2.4B | ||
| Q2 25 | $1.9B | $2.5B | ||
| Q1 25 | $1.9B | $2.5B | ||
| Q4 24 | $1.8B | $2.5B | ||
| Q3 24 | $1.8B | $2.5B | ||
| Q2 24 | $1.8B | $2.5B |
| Q1 26 | — | 1.53× | ||
| Q4 25 | — | 1.34× | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 1.39× | ||
| Q1 25 | — | 1.49× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $110.0M | $293.2M |
| Free Cash FlowOCF − Capex | $62.2M | $209.9M |
| FCF MarginFCF / Revenue | 16.0% | 60.6% |
| Capex IntensityCapex / Revenue | 12.3% | 9.5% |
| Cash ConversionOCF / Net Profit | 1.68× | 3.01× |
| TTM Free Cash FlowTrailing 4 quarters | $246.1M | $417.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $293.2M | ||
| Q4 25 | $110.0M | $93.6M | ||
| Q3 25 | $122.9M | $111.3M | ||
| Q2 25 | $81.6M | $17.4M | ||
| Q1 25 | $41.0M | $116.6M | ||
| Q4 24 | $86.6M | $43.8M | ||
| Q3 24 | $96.5M | $48.8M | ||
| Q2 24 | $57.3M | $-27.4M |
| Q1 26 | — | $209.9M | ||
| Q4 25 | $62.2M | $87.2M | ||
| Q3 25 | $100.3M | $106.3M | ||
| Q2 25 | $61.7M | $13.6M | ||
| Q1 25 | $21.9M | $100.9M | ||
| Q4 24 | $57.8M | $35.2M | ||
| Q3 24 | $77.1M | $39.4M | ||
| Q2 24 | $37.4M | $-33.1M |
| Q1 26 | — | 60.6% | ||
| Q4 25 | 16.0% | 25.7% | ||
| Q3 25 | 23.6% | 32.5% | ||
| Q2 25 | 14.5% | 4.2% | ||
| Q1 25 | 5.7% | 30.5% | ||
| Q4 24 | 15.7% | 10.1% | ||
| Q3 24 | 19.9% | 11.4% | ||
| Q2 24 | 10.2% | -9.8% |
| Q1 26 | — | 9.5% | ||
| Q4 25 | 12.3% | 1.9% | ||
| Q3 25 | 5.3% | 1.5% | ||
| Q2 25 | 4.7% | 1.2% | ||
| Q1 25 | 5.0% | 4.7% | ||
| Q4 24 | 7.8% | 2.5% | ||
| Q3 24 | 5.0% | 2.7% | ||
| Q2 24 | 5.5% | 1.7% |
| Q1 26 | — | 3.01× | ||
| Q4 25 | 1.68× | 2.09× | ||
| Q3 25 | 1.42× | 2.88× | ||
| Q2 25 | 0.93× | 0.51× | ||
| Q1 25 | 0.59× | 2.01× | ||
| Q4 24 | 1.39× | 1.17× | ||
| Q3 24 | 1.25× | 1.44× | ||
| Q2 24 | 0.87× | -0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AWI
| Distributors | $183.0M | 47% |
| Architectural Specialties | $143.7M | 37% |
| Home Centers | $27.2M | 7% |
| Retailers And Other | $21.7M | 6% |
| Direct Customers | $12.7M | 3% |
HAE
| Hospital | $159.6M | 46% |
| Plasma | $130.3M | 38% |
| Blood Center | $56.4M | 16% |
